American Health Council Recognizes Glenn Taylor, MD, FAAOS as “America’s Best Doctor”
Oct 20, 2017 12:00 pm UTC| Business
NEW YORK, Oct. 20, 2017 -- Dr. Glenn G. Taylor of NOSS – Neurosurgery, Orthopedics Spine Specialists, PC, Waterbury, Connecticut, has been recognized as “America’s Best Doctor” by the American Health Council. He will...
Twin Disc, Inc. Announces Fiscal 2018 First-Quarter Earnings Conference Call and Press Release
Oct 20, 2017 12:00 pm UTC| Business
RACINE, Wis., Oct. 20, 2017 -- Twin Disc, Inc. (NASDAQ:TWIN), today announced that it will release its fiscal 2018 first-quarter financial results before the market opens on Friday, October 27, 2017. In conjunction...
Sotheby’s Third Quarter 2017 Earnings Conference Call Invitation
Oct 20, 2017 12:00 pm UTC| Business
NEW YORK, Oct. 20, 2017 -- Sotheby’s (NYSE:BID) will be holding its third quarter and nine months ended September 30, 2017 earnings conference call on Friday, November 3, 2017 at 9:00 AM EDT. The call will be hosted by...
Spero Therapeutics Initiates Clinical Program for Oral Carbapenem SPR994
Oct 20, 2017 12:00 pm UTC| Business
Clinical study to evaluate potential first ever orally administered carbapenem being developed for multi-drug resistant (MDR) Gram-negative infectionsInitiation of pivotal Phase 3 clinical trial in patients with...
Gentex Reports Third Quarter 2017 Financial Results
Oct 20, 2017 12:00 pm UTC| Business
ZEELAND, Mich., Oct. 20, 2017 -- Gentex Corporation (NASDAQ:GNTX) the Zeeland, Michigan-based manufacturer of automotive automatic-dimming rearview mirrors, automotive electronics, dimmable aircraft windows, and fire...
Oct 20, 2017 12:00 pm UTC| Business
Inarigivir Phase 2 results confirm antiviral activity novel mechanism of action Data Safety Monitoring Board approves proceeding with enrollment of third cohort (inarigivir 100mg) of the ACHIEVE trial HOPKINTON,...
Oct 20, 2017 12:00 pm UTC| Business
— A4250 reduced serum bile acids and improved pruritus in most patients, exhibited a favorable overall tolerability profile — — Albireo to conduct Phase 3 study in children with progressive familial intrahepatic...